SPECTRABOOST Trademark
Trademark Overview
On Friday, January 23, 2026, a trademark application was filed for SPECTRABOOST with the United States Patent and Trademark Office. The USPTO has given the SPECTRABOOST trademark a serial number of 99612183. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, June 4, 2026. This trademark is owned by Revant, LLC. The SPECTRABOOST trademark is filed in the Medical Instrument Products category with the following description:
Lenses for sunglasses; Sunglasses
General Information
| Serial Number | 99612183 |
| Word Mark | SPECTRABOOST |
| Filing Date | Friday, January 23, 2026 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, June 4, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 23, 2026 |
Trademark Statements
| Goods and Services | Lenses for sunglasses; Sunglasses |
Classification Information
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 23, 2026 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Revant, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Portland, OR 97209
US |
Trademark Events
| Event Date | Event Description |
| Friday, January 23, 2026 | NEW APPLICATION ENTERED |
| Friday, January 23, 2026 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, May 13, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 21, 2026 | ASSIGNED TO EXAMINER |
| Thursday, May 28, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
